Get started
VIVORYON THERAPEUTICS NVVIVORYON THERAPEUTICS NVVIVORYON THERAPEUTICS NV

VIVORYON THERAPEUTICS NV

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast

VVYN chart


Full chart

Key stats


Market capitalization
‪45.67 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−28.34 M‬ EUR
Revenue (FY)
‪−3.62 M‬ EUR
Shares float
‪20.19 M‬
Beta (1Y)
2.39

Employees


Employees (FY)
17
Change (1Y)
0
Revenue / Employee (1Y)
‪−212.94 K‬ EUR
Net income / Employee (1Y)
‪−1.67 M‬ EUR

About VIVORYON THERAPEUTICS N.V.


Sector
Health Technology
Industry
Biotechnology
CEO
Frank T. Weber
Website
vivoryon.com
Headquarters
Halle
Founded
2001
ISIN
NL00150002Q7
FIGI
BBG01T4QDKH6
Vivoryon Therapeutics NV is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

VVYN news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Check out other big names from the same industry as VVYN.

Frequently Asked Questions


The current price of VVYN is 1.732 EUR — it has increased by 1.76% in the past 24 hours. Watch VIVORYON THERAPEUTICS NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange VIVORYON THERAPEUTICS NV stocks are traded under the ticker VVYN.
VVYN stock has fallen by −3.46% compared to the previous week, the month change is a −11.18% fall, over the last year VIVORYON THERAPEUTICS NV has showed a −11.18% decrease.
We've gathered analysts' opinions on VIVORYON THERAPEUTICS NV future price: according to them, VVYN price has a max estimate of 9.00 EUR and a min estimate of 2.00 EUR. Watch VVYN chart and read a more detailed VIVORYON THERAPEUTICS NV stock forecast: see what analysts think of VIVORYON THERAPEUTICS NV and suggest that you do with its stocks.
VVYN reached its all-time high on Mar 24, 2025 with the price of 1.988 EUR, and its all-time low was 1.632 EUR and was reached on Apr 7, 2025. View more price dynamics on VVYN chart.
See other stocks reaching their highest and lowest prices.
VVYN stock is 4.17% volatile and has beta coefficient of 2.39. Track VIVORYON THERAPEUTICS NV stock price on the chart and check out the list of the most volatile stocks — is VIVORYON THERAPEUTICS NV there?
Today VIVORYON THERAPEUTICS NV has the market capitalization of ‪45.67 M‬, it has decreased by −6.02% over the last week.
Yes, you can track VIVORYON THERAPEUTICS NV financials in yearly and quarterly reports right on TradingView.
No, VVYN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 19, 2025, the company has 17 employees. See our rating of the largest employees — is VIVORYON THERAPEUTICS NV on this list?
Like other stocks, VVYN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIVORYON THERAPEUTICS NV stock right from TradingView charts — choose your broker and connect to your account.